Eva Groß

2.2k total citations
34 papers, 968 citations indexed

About

Eva Groß is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Eva Groß has authored 34 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 14 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Eva Groß's work include BRCA gene mutations in cancer (7 papers), Biochemical and Molecular Research (7 papers) and Colorectal Cancer Treatments and Studies (7 papers). Eva Groß is often cited by papers focused on BRCA gene mutations in cancer (7 papers), Biochemical and Molecular Research (7 papers) and Colorectal Cancer Treatments and Studies (7 papers). Eva Groß collaborates with scholars based in Germany, Netherlands and United States. Eva Groß's co-authors include Marion Kiechle, Norbert Arnold, Katharina Seck, Manfred Schmitt, Jacobus Pfisterer, Ulrike Schwarz‐Boeger, W. Jonat, Thomas Ruzicka, Katharina Pfeifer and Laëtitia Dahan and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Eva Groß

34 papers receiving 943 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Groß Germany 18 547 445 158 154 118 34 968
Verena Materna Germany 20 552 1.0× 632 1.4× 109 0.7× 220 1.4× 99 0.8× 33 1.1k
Petra Kristel Netherlands 14 760 1.4× 643 1.4× 154 1.0× 271 1.8× 86 0.7× 19 1.2k
H. Meden Germany 19 355 0.6× 492 1.1× 118 0.7× 146 0.9× 141 1.2× 68 1.0k
Hirokazu Kurokawa Japan 13 511 0.9× 555 1.2× 287 1.8× 154 1.0× 49 0.4× 29 913
F A Firgaira Australia 18 518 0.9× 471 1.1× 121 0.8× 215 1.4× 87 0.7× 32 1.2k
Letícia Batista Azevedo Rangel Brazil 14 568 1.0× 284 0.6× 111 0.7× 280 1.8× 66 0.6× 39 1.1k
Jin-Song Lu China 16 499 0.9× 492 1.1× 223 1.4× 465 3.0× 112 0.9× 20 1.1k
Eftihia Cocolakis Canada 12 898 1.6× 342 0.8× 83 0.5× 120 0.8× 69 0.6× 20 1.2k
R Silvestrini Italy 14 507 0.9× 558 1.3× 79 0.5× 252 1.6× 96 0.8× 29 969
Silvia J. Serrano‐Gómez Colombia 12 494 0.9× 349 0.8× 102 0.6× 327 2.1× 74 0.6× 21 913

Countries citing papers authored by Eva Groß

Since Specialization
Citations

This map shows the geographic impact of Eva Groß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Groß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Groß more than expected).

Fields of papers citing papers by Eva Groß

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Groß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Groß. The network helps show where Eva Groß may publish in the future.

Co-authorship network of co-authors of Eva Groß

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Groß. A scholar is included among the top collaborators of Eva Groß based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Groß. Eva Groß is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grill, Sabine, Juliane Ramser, Heide Hellebrand, et al.. (2020). TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge. Archives of Gynecology and Obstetrics. 303(6). 1557–1567. 6 indexed citations
2.
LaRoche, Kathryn J., et al.. (2018). Put a Ring in It: Exploring Women's Experiences with the Contraceptive Vaginal Ring in Ontario. Women s Health Issues. 28(5). 415–420. 3 indexed citations
3.
Braselmann, Herbert, Annette Feuchtinger, Sara Molatore, et al.. (2016). uPAR enhances malignant potential of triple-negative breast cancer by directly interacting with uPA and IGF1R. BMC Cancer. 16(1). 615–615. 28 indexed citations
4.
5.
Groß, Eva, et al.. (2014). Alternative splicing of KAI1 abrogates its tumor-suppressive effects on integrin αvβ3-mediated ovarian cancer biology. Cellular Signalling. 27(3). 652–662. 20 indexed citations
6.
Magdolen, Viktor, Tibor Schuster, Matthias Kotzsch, et al.. (2013). Downregulation of Serine Protease HTRA1 Is Associated with Poor Survival in Breast Cancer. PLoS ONE. 8(4). e60359–e60359. 34 indexed citations
7.
Hellebrand, Heide, Christian Sutter, Ellen Honisch, et al.. (2011). Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer. Human Mutation. 32(6). E2176–E2188. 36 indexed citations
8.
Goettig, Peter, Dorothea Haas, Viktor Magdolen, et al.. (2011). A mild phenotype of dihydropyrimidine dehydrogenase deficiency and developmental retardation associated with a missense mutation affecting cofactor binding. Clinical Biochemistry. 44(8-9). 722–724. 6 indexed citations
9.
Kuilenburg, André B. P., Judith Meijer, Adri N. Mul, et al.. (2010). Intragenic deletions and a deep intronic mutation affecting pre-mRNA splicing in the dihydropyrimidine dehydrogenase gene as novel mechanisms causing 5-fluorouracil toxicity. Human Genetics. 128(5). 529–538. 93 indexed citations
10.
Hutzler, Peter, Matthias Kotzsch, Birgit Luber, et al.. (2009). Tumor suppressor KAI1 affects integrin αvβ3-mediated ovarian cancer cell adhesion, motility, and proliferation. Experimental Cell Research. 315(10). 1759–1771. 42 indexed citations
11.
Groß, Eva, et al.. (2007). Mutational spectrum of dihydropyrimidine dehydrogenase gene (DPYD) in the Tunisian population. Comptes Rendus Biologies. 330(10). 764–769. 17 indexed citations
12.
Groß, Eva, Norbert Arnold, Anja Jacobsen, et al.. (2006). Allelic loss analysis by denaturing high-performance liquid chromatography and electrospray ionization mass spectrometry. Human Mutation. 28(3). 303–311. 3 indexed citations
13.
Groß, Eva, Marion Kiechle, & Norbert Arnold. (2001). Mutation analysis of p53 in ovarian tumors by DHPLC. Journal of Biochemical and Biophysical Methods. 47(1-2). 73–81. 47 indexed citations
14.
Kiechle, Marion, Eva Groß, Ulrike Schwarz‐Boeger, et al.. (2000). Ten novelBRCA1 andBRCA2 mutations in breast and/or ovarian cancer families from northern Germany. Human Mutation. 16(6). 529–530. 7 indexed citations
15.
Arnold, Norbert, Eva Groß, Ulrike Schwarz‐Boeger, et al.. (1999). A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers. Human Mutation. 14(4). 333–339. 90 indexed citations
16.
Kemény, Lajos, B. Przybilla, Eva Groß, Petr Arenberger, & Thomas Ruzicka. (1991). Inhibition of 12(S)-Hydroxyeicosatetraenoic Acid [12(S)-HETE] Binding to Epidermal Cells by Ultraviolet-B. Journal of Investigative Dermatology. 97(6). 1028–1031. 4 indexed citations
17.
Groß, Eva, et al.. (1990). High-Affinity Binding and Lack of Growth-Promoting Activity of 12(S)-Hydroxyeicosatetraenoic Acid (12(S)-HETE) in a Human Epidermal Cell Line. Journal of Investigative Dermatology. 94(4). 446–451. 27 indexed citations
18.
Arenberger, Petr, et al.. (1990). Regulation of 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) binding sites on human epidermal cells by interferon-γ. Experimental Cell Research. 191(2). 204–208. 12 indexed citations
19.
Meier, Friedegund, Eva Groß, Karl‐Norbert Klotz, & Thomas Ruzicka. (1989). Leukotriene B<sub>4</sub> Receptors on Neutrophils in Patients with Psoriasis and Atopic Eczema. Skin Pharmacology and Physiology. 2(2). 61–67. 10 indexed citations
20.
Groß, Eva, et al.. (1988). Evidence for LTB4/12-hete binding sites in a human epidermal cell line. Prostaglandins. 36(1). 49–58. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Verena Materna Breakdown of academic impact, for papers by Petra Kristel Breakdown of academic impact, for papers by H. Meden Breakdown of academic impact, for papers by Hirokazu Kurokawa Breakdown of academic impact, for papers by F A Firgaira Breakdown of academic impact, for papers by Letícia Batista Azevedo Rangel Breakdown of academic impact, for papers by Jin-Song Lu Breakdown of academic impact, for papers by Eftihia Cocolakis Breakdown of academic impact, for papers by R Silvestrini Breakdown of academic impact, for papers by Silvia J. Serrano‐Gómez
Rankless by CCL
2026